pI: 6.6447 |
Length (AA): 452 |
MW (Da): 47499 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
29 | 449 | 3pvs (A) | 14 | 440 | 42.00 | 0 | 1 | 1.32602 | 0.54 |
30 | 232 | 1iqp (A) | 14 | 216 | 31.00 | 0.00000000031 | 1 | 0.759815 | 0.11 |
68 | 171 | 4lcb (A) | 131 | 257 | 29.00 | 0.01 | 0.85 | 0.560789 | -0.24 |
262 | 444 | 3bge (A) | 251 | 434 | 49.00 | 0 | 1 | 0.835567 | 0.31 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Dormant phase. | murphy |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Dormant phase. | hasan |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
Ortholog group members (OG5_128067)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G24290 | AAA-type ATPase-like protein |
Candida albicans | CaO19.3019 | similar to subunits E. coli DNA polymerase III |
Candida albicans | CaO19.10537 | similar to subunits E. coli DNA polymerase III |
Dictyostelium discoideum | DDB_G0272158 | hypothetical protein |
Escherichia coli | b0892 | DNA-dependent ATPase involved in processing recombination intermediates at replication forks |
Entamoeba histolytica | EHI_130980 | AAA family ATPase, putative |
Entamoeba histolytica | EHI_045050 | AAA family ATPase, putative |
Giardia lamblia | GL50803_22138 | ATPase, AAA family |
Homo sapiens | ENSG00000124535 | Werner helicase interacting protein 1 |
Mycobacterium leprae | ML0510 | Conserved hypothetical protein |
Mus musculus | ENSMUSG00000021400 | Werner helicase interacting protein 1 |
Mycobacterium tuberculosis | Rv2559c | Conserved hypothetical alanine leucine valine rich protein |
Mycobacterium ulcerans | MUL_1751 | recombination factor protein RarA |
Neospora caninum | NCLIV_066740 | ATPase, AAA family domain containing protein, putative |
Plasmodium berghei | PBANKA_0935000 | conserved Plasmodium protein, unknown function |
Plasmodium falciparum | PF3D7_1112600 | DNA helicase, putative |
Plasmodium knowlesi | PKNH_0910300 | conserved Plasmodium protein, unknown function |
Plasmodium vivax | PVX_091280 | hypothetical protein, conserved |
Plasmodium yoelii | PY05480 | putative helicase RUVBL |
Saccharomyces cerevisiae | YNL218W | ssDNA-dependent ATPase MGS1 |
Toxoplasma gondii | TGME49_251670 | werner helicase interacting protein 1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2603 this record | Mycobacterium tuberculosis | non-essential | nmpdr |
b0892 | Escherichia coli | non-essential | goodall |
TGME49_251670 | Toxoplasma gondii | Probably non-essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.